Company / Free Cash Flow per Share
TherapeuticsMD, Inc. Free Cash Flow per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$6.42
FY2022
5-year range
-$6.42 / -$0.39
FY2018-FY2022
Trend
-1043.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -1044% YoY in FY2022, a notable deviation from the 7-year average annual change of -175%.
Based on SEC 10-K filings.
-6.42 in FY2022.
Declined from $-0.39 to $-6.42 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TherapeuticsMD, Inc.'s free cash flow per share has declined for 3 consecutive years.
- In FY2022, free cash flow per share decreased 1043.7% year-over-year.
- Peak free cash flow per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$6.42 | -1043.7% |
| FY2021 | -$0.56 | -42.1% |
| FY2020 | -$0.39 | -24.5% |
| FY2019 | -$0.32 | +1.3% |
| FY2018 | -$0.32 | +20.2% |
| FY2017 | -$0.40 | -57.3% |
| FY2016 | -$0.26 | -78.4% |
| FY2015 | -$0.14 | -62.5% |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026